The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Oxford Biomedical Research Inc

  • Contact Person: Denis Callewaert
  • Contact Phone: 810-678-2008
  • Contact Email: dcallew@oxfordbiomed.com
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • For Profit Organization
  • Manufacturer of Goods
  • Industries Served: Biological Product (except Diagnostic) Manufacturing
  • Product Areas: IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS, IN VITRO DIAGNO SUBSTANCES,REAGENTS, R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), LIFE SCIENCES (APPLIED/EXPLORATORY), R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH), BIOMEDICAL (BASIC), R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), BIOMEDICAL (APPLIED/EXPLORATORY), BIOMEDICAL (ADVANCED), R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT), R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), R&D-OTHER R & D-A RES/EXPL DEV, R&D- OTHER RESEARCH AND DEVELOPMENT (ADVANCED DEVELOPMENT), R&D-OTHER R & D-ADV DEV

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $39,580 - Monday the 25th of August 2014
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    OXFORD BIOMEDICAL RESEARCH - AMBIS# 1596521

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.